Cite
Cloux AJ, Aubry D, Heulot M, et al. Reactive oxygen/nitrogen species contribute substantially to the antileukemia effect of APO866, a NAD lowering agent. Oncotarget. 2019;10(62):6723-6738doi: 10.18632/oncotarget.27336.
Cloux, A. J., Aubry, D., Heulot, M., Widmann, C., ElMokh, O., Piacente, F., Cea, M., Nencioni, A., Bellotti, A., Bouzourène, K., Pellegrin, M., Mazzolai, L., Duchosal, M. A., & Nahimana, A. (2019). Reactive oxygen/nitrogen species contribute substantially to the antileukemia effect of APO866, a NAD lowering agent. Oncotarget, 10(62), 6723-6738. https://doi.org/10.18632/oncotarget.27336
Cloux, Anne-Julie, et al. "Reactive oxygen/nitrogen species contribute substantially to the antileukemia effect of APO866, a NAD lowering agent." Oncotarget vol. 10,62 (2019): 6723-6738. doi: https://doi.org/10.18632/oncotarget.27336
Cloux AJ, Aubry D, Heulot M, Widmann C, ElMokh O, Piacente F, Cea M, Nencioni A, Bellotti A, Bouzourène K, Pellegrin M, Mazzolai L, Duchosal MA, Nahimana A. Reactive oxygen/nitrogen species contribute substantially to the antileukemia effect of APO866, a NAD lowering agent. Oncotarget. 2019 Nov 19;10(62):6723-6738. doi: 10.18632/oncotarget.27336. eCollection 2019 Nov 19. PMID: 31803365; PMCID: PMC6877101.
Copy
Download .nbib